VOTING AGREEMENT
VOTING
AGREEMENT , dated as of
September __, 2009, between James MacKay (“ MacKay
”), individually, and ValiRx Plc. (“ ValiRx
”), (each, a " Shareholder " and together, the "
Shareholders ").
WHEREAS :
A. As of the
date hereof, MacKay owns, beneficially and/or of record, 12,300,000
shares of preferred stock, $0.001 par value per share (the "
Preferred Stock "), of Biofield Corp., a Delaware
corporation (the " Company ");
B. The
Shareholders have entered into a Letter Agreement dated September
__, 2009 (the “Letter Agreement”), whereby MacKay has
pledged as security One Million Five Hundred Thousand (1,500,000)
shares of the Preferred Stock to ValiRx (the “ Pledged
Shares ”);
C. Each
Shareholder desires to enter into this Agreement with respect to
the voting of the Pledged Shares now held, beneficially and/or of
record, by ValiRx on the terms and conditions set forth
herein.
NOW,
THEREFORE , in consideration of the foregoing and the mutual
covenants and agreements contained herein, and intending to be
legally bound hereby, the parties hereto agree as
follows:
1. Agreement to
Vote. (a) In recognition of the Shareholders' common goals and
objectives as shareholders of the Company and to ensure the orderly
management and operation of the Company, each Shareholder hereby
agrees that during the time this Agreement is in effect, at any
meeting of the shareholders of the Company, however called, and in
any action by consent of the shareholders of the Company, MacKay
shall:
(a) appear at the meeting or otherwise cause the
Pledged Shares to be counted as present thereat for purposes of
establishing a quorum;
(b) vote, or execute consents in respect of the
Pledged Shares, or cause the Pledged Shares to be voted, or
consents to be executed in respect thereof, in a manner that he
believes is in the best interest of the Company and its
shareholders;
2. Irrevocable Proxy. ValiRx hereby
irrevocably constitutes and appoints MacKay as its attorney and
proxy in accordance with Delaware Corporate Law, with full power of
substitution and re-substitution, to cause the Pledged Shares to be
counted as present at any Company Stockholders Meetings to vote
his, her or its shares at any Company Stockholders' Meeting,
however called, and execute consents in respect of his, her or its
shares as and to the extent provided in Section 1. THIS PROXY AND
POWER OF ATTORNEY UPON ITS EFFECTIVENESS WILL BE IRREVOCABLE AND
COUPLED WITH AN INTEREST. ValiRx hereby revokes all other proxies
and powers of attorney with respect to his, her or its shares that
he, she or it may have heretofore appointed or granted, and no
subsequent proxy or power of attorney shall be granted, in each
case to the extent such prior or subsequent proxies or powers of
attorney would prevent ValiRx from complying with such
stockholder's obligations under this Agreement.
3. Legend. Any stock certificates representing the
Pledged Shares owned by a Shareholder shall bear an appropriate
legend relating to this Agreement.
4.
Representations and Warranties of the MacKay. MacKay hereby
represents and warrants to Stockholder as follows:
(a)
Due Authorization; Enforceability. MacKay has full power and
authority to execute and deliver this Agreement. The execution and
delivery of this Agreement and the consummation of the transactions
contemplated hereby have been duly and validly authorized by all
necessary action on the part of MacKay, and no other proceedings on
the part of MacKay are necessary to authorize this Agreement or to
consummate the transactions contemplated hereby. This Agreement has
been duly and validly executed and delivered by MacKay and
constitutes a valid and binding agreement by MacKay, enforceable
against such Stockholder in accordance with its terms, subject to
applicable bankruptcy, insolvency, moratorium or other similar laws
relating to creditors' rights and to general principles of
equity.
(b)
No Conflicts. No authorization, consent or approval of, or filing
with, any court or any public body or authority is necessary for
the consummation by the Stockholder of the transactions
contemplated by this Agreement. The execution, delivery and
performance of this Agreement by the Stockholder will not
constitute a breach, violation or default (or any event which, with
notice or lapse of time or both, would constitute a default) under,
or result in the termination of, or accelerate the performance
required by, or result in a right of termination or acceleration
under, or result in the creation of any lien or encumbrance upon
any of the properties or assets of such Stockholder under, any
note
|